Intermediates and key starting materials (KSMs) are where multi-step API synthesis actually begins: the chemical building blocks every active pharmaceutical ingredient is assembled from. Whatever purity, consistency and reproducibility you achieve at this stage carries straight through into the safety, efficacy and stability of the finished medicine.
Long experience developing and manufacturing these materials is what gives our partners a supply chain they can rely on: a controlled, compliant path running from raw input all the way to finished API.
Start a ProjectIdentifying and refining the most efficient, scalable and economical synthetic pathway to the target API.
Carrying processes from bench through clinical and on to commercial volumes without losing reproducibility or batch-to-batch consistency.
Manufacture takes place in facilities aligned to ICH Q7 Good Manufacturing Practice, keeping quality uniform from one campaign to the next.
In-process and release testing by mass spectrometry, NMR and HPLC confirms the structure, purity and consistency of every lot.
Current synthetic methodology paired with process-optimisation tooling lets us produce a wide range of drug intermediates.
Submission-grade documentation and characterisation prepared to ICH guidelines, ready for filings in any market.
What happens at the intermediate stage determines the safety, efficacy and stability of the medicine that follows. Our workflows are built so quality is never the thing that varies.